Published in Medical Device Law Weekly, November 23rd, 2008
"Eleven eyes of 11 patients with submacular hemorrhage and CNV due to age-related macular degeneration (n = 10) or angioid streaks (n = 1). All patients were treatment naive except for a single dose of intravitreal injection of bevacizumab (1.25 mg/50 mu L dose) and subsequent vitrectomy after various intervals (1-101 days) because of active and progressive lesion. Intravitreal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.